InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
67,350.64
(
0.95%
)
Post# of 252642
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 120692

Tuesday, 05/31/2011 11:39:48 PM

Tuesday, May 31, 2011 11:39:48 PM

Post# of 252642
>Enemy action

But there is the confounding Arbiter 6-HALTS trial where Niaspan plus statin was shown to be superior (based on CIMT) to Zetia plus statin.

http://content.onlinejacc.org/cgi/content/full/j.jacc.2010.03.017v1

Maybe carotid intima-media thickness isn't in fact a good endpoint or maybe Zetia actually did harm.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up